Clinical trial
Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic…
NCT00371150 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00371150 |
|---|---|
| Title | Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection |
| Official title | A Study to Describe the Antiviral Effect of Entecavir (ETV) in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection Who Are Nucleoside-Naive |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis B Infection |
| Intervention type | Drug |
| Interventions | Entecavir |
| Enrollment | 131 |
| Start date | Nov 1, 2006 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Sep 1, 2006 |
| Last update posted | Apr 16, 2012 |
| Countries | Brazil, Mexico, Puerto Rico, South Africa, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: